MedPath

ong-term renoprotective effect of SGLT2 inhibitors

Not Applicable
Conditions
type 2 diabetes melllitus
Registration Number
JPRN-UMIN000034387
Lead Sponsor
ephrology Division, JA Toride Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

nothing particular

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
decline rate of eGFR three years before and afater administration of SGLT2 inhibitors
Secondary Outcome Measures
NameTimeMethod
clinical factors affecting decline rate of eGFR before and afater administration of SGLT2 inhibitors quantitative changes of albuminuria and proteinuria
© Copyright 2025. All Rights Reserved by MedPath